Navigation Links
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Date:7/15/2008

Study Reports 92 Percent Response Rate to Combination Treatment

FRAZER, Pa., July 15 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that in a phase 2 study published online today in the Journal of Clinical Oncology, 92 percent of patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma (NHL) responded to treatment with TREANDA(R) (bendamustine hydrochloride) for Injection plus rituximab. This combination study is one of three studies in patients with NHL that Cephalon submitted in December 2007 to the U.S. Food and Drug Administration requesting approval of TREANDA for the treatment of patients with indolent NHL who have progressed during or following treatment with rituximab or a rituximab-containing regimen. TREANDA was approved by the FDA in March 2008 for the treatment of patients with chronic lymphocytic leukemia and is not currently approved for use in NHL.

"A variety of treatment options have been employed in patients with indolent B-cell and mantle cell lymphomas, but resistance to treatment in this patient population often limits effective therapeutic options," said Dr. Charles Morris, Vice President, Worldwide Clinical Research at Cephalon. "Based on what we saw in this study, the combination of TREANDA with rituximab appears to elicit a high rate of durable responses and encouraging progression-free survival."

About the Study

In this multi-center, open-label, single arm, Phase 2 study, 66 patients with relapsed, indolent B-cell or mantle cell lymphoma without documented resistance to prior rituximab therapy were treated. Patients received rituximab 375 mg/meter squared intravenously on day one and TREANDA 90 mg/meter squared intravenously on days two and three of a 28-day cycle for up to six cycles. An additional dose of rituximab was given one week before the first cycle and four weeks after the last cycle.

Overall response rate was 92 percent with a complete respon
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
2. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
3. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
4. Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
5. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
8. Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
9. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
10. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
11. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... LOS ANGELES , April 21, 2015 /PRNewswire/ ... today that Pradaxa,s maker, Boehringer Ingelheim Pharmaceuticals, is ... treat DVT and PE. According to PBR, Boehringer ... the FDA in hopes that Pradaxa will be ... (DVT) and pulmonary embolism (PE) for patients who ...
(Date:4/20/2015)... NEW YORK , April 20, 2015 This ... Units by the following Product Segments: Non-Powered Breast Pumps, and ... the US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts ... seven-year historic analysis is provided for these markets. Market data ...
(Date:4/20/2015)... , April 20, 2015 This report analyzes ... the following Segments: Toxicology Testing (In-Vivo, & In-Vitro), and ADME ... Canada , Japan , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. Market data and analytics ...
Breaking Medicine Technology:Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3World Breast Pumps Industry 2World Breast Pumps Industry 3World Breast Pumps Industry 4World Breast Pumps Industry 5World Breast Pumps Industry 6World Breast Pumps Industry 7World Breast Pumps Industry 8World Breast Pumps Industry 9World Breast Pumps Industry 10World Breast Pumps Industry 11World Breast Pumps Industry 12World Breast Pumps Industry 13World Breast Pumps Industry 14World ADME-Toxicology Testing Industry 2World ADME-Toxicology Testing Industry 3World ADME-Toxicology Testing Industry 4World ADME-Toxicology Testing Industry 5World ADME-Toxicology Testing Industry 6World ADME-Toxicology Testing Industry 7World ADME-Toxicology Testing Industry 8World ADME-Toxicology Testing Industry 9World ADME-Toxicology Testing Industry 10World ADME-Toxicology Testing Industry 11World ADME-Toxicology Testing Industry 12World ADME-Toxicology Testing Industry 13World ADME-Toxicology Testing Industry 14World ADME-Toxicology Testing Industry 15World ADME-Toxicology Testing Industry 16World ADME-Toxicology Testing Industry 17World ADME-Toxicology Testing Industry 18World ADME-Toxicology Testing Industry 19
... of the premier providers of innovative supplies for continuous ... of its fifth year with a variety of planned ... the high-quality standards and innovation that the home health ... Circadiance has its sights set on being ...
... Jan. 13, 2012 IBM (NYSE: IBM ) ... made from silicon that can aid researchers and ... drug discovery and disease diagnostics. ... Tissue staining is widely used in pathology to ...
Cached Medicine Technology:Circadiance to Launch New Respiratory Supply Products 2MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 2MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 3MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 4
(Date:4/21/2015)... City, Utah (PRWEB) April 21, 2015 ... for small businesses, announced today the publication of a ... Recent health reform brought changes to the health insurance ... caused some business owners to question what is permitted ... eBook helps small business owners determine which HRAs are ...
(Date:4/21/2015)... 2015 Autocarsinsurancetips.com has released a new ... auto insurance plans by comparing quotes. , ... the best policies in their neighborhood. The insurance market ... best offer simply by comparing different plans. , ... car insurance quotes. Insurance brokerage websites like http://autocarsinsurancetips.com/ ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Carinsurancesavings.biz has released ... car under proper surveillance and explaining the impact on a ... their vehicles safe and supervised may be eligible for advantageous ... plans in a simple and efficient way. This will also ... a convenient and simple way. , Finding low cost coverage ...
(Date:4/21/2015)... LifeWings Partners LLC today announced a toolkit to ... safety programs by getting more support from their physicians. ... ways to get more physician support and engagement in ... Act, the new model of health care reimbursement is ... volume of services. Health care leaders feel an increased ...
(Date:4/21/2015)... April 21, 2015 When a bandage ... can result. In order to solve this problem two ... Bandaging. , This improved bandage helps a cut, burn, ... pain and enhances air exposure. The bandage is easy ... The original design was submitted to the St. Louis ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes Can Help Clients Save Money 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:LifeWings Announces New Physician Engagement Toolkit to Help Hospitals Weather Serious Ramifications of the Affordable Care Act 2
... order to effectively handle the situation in case of an ... to make all necessary preparation.// They are asked to appoint ... European Union would also have to look harder at immediate ... 25 countries. ,He said that their problem is ...
... of psychological stress in the expectant mother might prove ... the Johns Hopkins University and the National Institute of ... in the May/June 2006 edition of the journal Child ... daily stress during pregnancy is associated with more advanced ...
... Space Research Organization (ISRO) announced expansion of its ... hospitals in the country.// Manipal hospital in Banglore, ... Medical Foundation in Maharashtra and Madras Diabetic Research ... ,The telemedicine network, which began in 2001 ...
... its characteristic red color has been discovered to possess ... and heart attacks.// Previous studies have already established cancer ... scientists, the stickiness of platelets - the particles in ... percent when 220 volunteers had a drink containing the ...
... study appearing in the American Journal of Respiratory and Critical ... 11 had a loss in lung capacity equivalent to what ... the terror attacks. ,An average loss of 372 ... the lung's capacity. This loss is at least 10 times ...
... on Monday the major hospitals in Delhi revoked the leave ... were away from duty were recalled. // ,"The ... of Medical Sciences (AIIMS) as resident doctors are on an ... have cancelled all the leave applications and recalled the doctors ...
Cached Medicine News:Health News:Children Benefited By Moderate Maternal Stress? 2Health News:ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included 2Health News:Delhi Hospitals Cancel Holidays And Recalls Doctors 2Health News:Delhi Hospitals Cancel Holidays And Recalls Doctors 3
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: